GZMB and neoplasm: Roseburia intestinalis inhibits tumor growth by inducing cytotoxic granzyme B+, IFN‐γ, and TNF‐α + CD8 + T cells, significantly enhancing the anti‐PD‐1 efficacy in mice carrying MSI low CT26 tumors.